The role of human CYP2C8 in the metabolizing of montelukast-like compounds: a computational study

作者: Rahim Ghadari

DOI: 10.1007/S11164-017-2911-X

关键词:

摘要: Docking studies on the selected montelukast-like molecules with CYP2C8 enzyme were done to investigate their interactions. The results showed that some of investigated structures have competition montelukast bind CYP2C8, based similarity binding energies. Based docking results, different interactions between and observable such as hydrogen bonding, σ–π, cation–π A interaction Arg241 chloroquinolin moiety was in most studied cases. bonding Ser100, Ser103, Asn217 amino acids carboxylate observable, well. CYP3A4, CYP2C9 role oxidize convert it more soluble compounds. This process by adding OH functional groups it. New can facilitate its excretion from body via kidneys making hydrophilic. Therefore, LogD values considered a measure ease excretion. calculated values, six will not obtain enough water solubility be excreted one oxidation is needed. Between structures, three them preferred site heme moiety. In total nine compounds need .

参考文章(30)
S. J. C. Davies, S. Eayrs, P. Pratt, M. S. Lennard, Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards British Journal of Clinical Pharmacology. ,vol. 57, pp. 464- 472 ,(2004) , 10.1111/J.1365-2125.2003.02040.X
Kyoung-Ah Kim, Pil-Whan Park, Kyong Rae Kim, Ji-Young Park, Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans. British Journal of Clinical Pharmacology. ,vol. 63, pp. 339- 345 ,(2007) , 10.1111/J.1365-2125.2006.02764.X
L KAJOSAARI, M NIEMI, J BACKMAN, P NEUVONEN, Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide. Clinical Pharmacology & Therapeutics. ,vol. 79, pp. 231- 242 ,(2006) , 10.1016/J.CLPT.2005.11.002
T Karonen, A Filppula, J Laitila, M Niemi, P J Neuvonen, J T Backman, Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast. Clinical Pharmacology & Therapeutics. ,vol. 88, pp. 223- 230 ,(2010) , 10.1038/CLPT.2010.73
Guillaume A. Schoch, Jason K. Yano, Stefaan Sansen, Patrick M. Dansette, C. David Stout, Eric F. Johnson, Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid. Journal of Biological Chemistry. ,vol. 283, pp. 17227- 17237 ,(2008) , 10.1074/JBC.M802180200
Oytun Erbas, Montelukast Inhibits Pentylenetetrazol-Induced Seizures in Rats Medical Science Monitor. ,vol. 21, pp. 869- 874 ,(2015) , 10.12659/MSM.892932
Kuresh A. Youdim, Aref Zayed, Maurice Dickins, Alex Phipps, Michelle Griffiths, Amanda Darekar, Ruth Hyland, Odette Fahmi, Susan Hurst, David R. Plowchalk, Jack Cook, Feng Guo, R. Scott Obach, Application of CYP3A4 in vitro data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction British Journal of Clinical Pharmacology. ,vol. 65, pp. 680- 692 ,(2008) , 10.1111/J.1365-2125.2007.03070.X
Chris de Graaf, Nico P. E. Vermeulen, K. Anton Feenstra, Cytochrome P450 in Silico: An Integrative Modeling Approach Journal of Medicinal Chemistry. ,vol. 48, pp. 2725- 2755 ,(2005) , 10.1021/JM040180D
Marcus D Hanwell, Donald E Curtis, David C Lonie, Tim Vandermeersch, Eva Zurek, Geoffrey R Hutchison, Avogadro: an advanced semantic chemical editor, visualization, and analysis platform Journal of Cheminformatics. ,vol. 4, pp. 17- 17 ,(2012) , 10.1186/1758-2946-4-17